Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase

Brooke X. C. Kwai, Annabelle J. Collins, Martin J. Middleditch, Jonathan Sperry, Ghader Bashiri and Ivanhoe K. H. Leung

RSC Med. Chem., 2021, 12, 57
DOI: 10.1039/D0MD00301H

Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides

Jiraborrirak Charoenpattarapreeda, Yaw Sing Tan, Jessica Iegre, Stephen J. Walsh, Elaine Fowler, Rohan S. Eapen, Yuteng Wu, Hannah F. Sore, Chandra S. Verma, Laura Itzhaki and David R. Spring

Chem. Commun., 2019, 55, 7914
DOI: 10.1039/C9CC04022F

E3 ligase ligand chemistries: from building blocks to protein degraders

Izidor Sosič, Aleša Bricelj and Christian Steinebach

Chem. Soc. Rev., 2022, 51, 3487
DOI: 10.1039/D2CS00148A

Graph neural networks for identifying protein-reactive compounds

Victor Hugo Cano Gil and Christopher N. Rowley

Digital Discovery, 2024, 3, 1776
DOI: 10.1039/D4DD00038B

Advanced approaches of developing targeted covalent drugs

Conghao Gai, Suzannah J. Harnor, Shihao Zhang, Céline Cano, Chunlin Zhuang and Qingjie Zhao

RSC Med. Chem., 2022, 13, 1460
DOI: 10.1039/D2MD00216G

Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors

A. Keeley, P. Ábrányi-Balogh and G. M. Keserű

Med. Chem. Commun., 2019, 10, 263
DOI: 10.1039/C8MD00327K

A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors

Akihiro Kondo, Kazuhiro J. Fujimoto and Takeshi Yanai

Phys. Chem. Chem. Phys., 2023, 25, 20597
DOI: 10.1039/D3CP01723K

Advances in sulfonyl exchange chemical biology: expanding druggable target space

Lyn H. Jones

Chem. Sci., 2025, 16, 10119
DOI: 10.1039/D5SC02647D

Chemical technology principles for selective bioconjugation of proteins and antibodies

Preeti Chauhan, Ragendu V., Mohan Kumar, Rajib Molla, Surya Dev Mishra, Sneha Basa and Vishal Rai

Chem. Soc. Rev., 2024, 53, 380
DOI: 10.1039/D3CS00715D

Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization

Marc-André Kasper, Maria Glanz, Andreas Oder, Peter Schmieder, Jens P. von Kries and Christian P. R. Hackenberger

Chem. Sci., 2019, 10, 6322
DOI: 10.1039/C9SC01345H

Fragment-based covalent ligand discovery

Wenchao Lu, Milka Kostic, Tinghu Zhang, Jianwei Che, Matthew P. Patricelli, Lyn H. Jones, Edward T. Chouchani and Nathanael S. Gray

RSC Chem. Biol., 2021, 2, 354
DOI: 10.1039/D0CB00222D

Put a ring on it: application of small aliphatic rings in medicinal chemistry

Matthias R. Bauer, Paolo Di Fruscia, Simon C. C. Lucas, Iacovos N. Michaelides, Jennifer E. Nelson, R. Ian Storer and Benjamin C. Whitehurst

RSC Med. Chem., 2021, 12, 448
DOI: 10.1039/D0MD00370K

QM/MM and molecular dynamics investigation of the mechanism of covalent inhibition of TAK1 kinase

Borvornwat Toviwek, Duangkamol Gleeson and M. Paul Gleeson

Org. Biomol. Chem., 2021, 19, 1412
DOI: 10.1039/D0OB02273J

Recent applications of covalent chemistries in protein–protein interaction inhibitors

Alexandria M. Chan, Christopher C. Goodis, Elie G. Pommier and Steven Fletcher

RSC Med. Chem., 2022, 13, 921
DOI: 10.1039/D2MD00112H

Computational chemistry strategies in natural product synthesis

Masha Elkin and Timothy R. Newhouse

Chem. Soc. Rev., 2018, 47, 7830
DOI: 10.1039/C8CS00351C

Advances in covalent kinase inhibitors

Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl and Patrick T. Gunning

Chem. Soc. Rev., 2020, 49, 2617
DOI: 10.1039/C9CS00720B

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture

Jacob T. Bush, Robert K. Leśniak, Tzu-Lan Yeh, Roman Belle, Holger Kramer, Anthony Tumber, Rasheduzzaman Chowdhury, Emily Flashman, Jasmin Mecinović and Christopher J. Schofield

Chem. Commun., 2019, 55, 1020
DOI: 10.1039/C8CC07706A

A unique reaction of diphenylcyclopropenone and 1,2-aminothiol with the release of thiol for multiple bioconjugation

Shanshan Liu, Haishun Ye, Long Yi and Zhen Xi

Chem. Commun., 2023, 59, 1497
DOI: 10.1039/D2CC06419G

A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint

Sarah H. Naylon, Alexis D. Richaud, Guangkuan Zhao, Linda Bui, Craig P. Dufresne, Chunjing J. Wu, Medhi Wangpaichitr, Niramol Savaraj and Stéphane P. Roche

RSC Chem. Biol., 2024, 5, 1259
DOI: 10.1039/D4CB00174E

Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin

Ekaterina S. Sazanova, Iuliia A. Gracheva, Diane Allegro, Pascale Barbier, Sébastien Combes, Elena V. Svirshchevskaya and Alexey Yu Fedorov

RSC Med. Chem., 2020, 11, 696
DOI: 10.1039/D0MD00060D

Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations

Angus T. Voice, Gary Tresadern, Rebecca M. Twidale, Herman van Vlijmen and Adrian J. Mulholland

Chem. Sci., 2021, 12, 5511
DOI: 10.1039/D0SC06122K

Palladium-catalyzed in vivo bioorthogonal activation of N,N-dialkyl-α-hydroxymethyl acrylamide for efficient payload release

Ruipeng Shen, Baoxin Zhang, Jirong Liu, Meirong Yi, Yating Chen and Jianguo Fang

J. Mater. Chem. B, 2025
DOI: 10.1039/D5TB01090J

Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6

Xiyun Ye, Peiyuan Zhang, Jason Tao, John C. K. Wang, Amirhossein Mafi, Nathalie M. Grob, Anthony J. Quartararo, Hannah T. Baddock, Leanne J. G. Chan, Fiona E. McAllister, Ian Foe, Andrei Loas, Dan L. Eaton, Qi Hao, Aaron H. Nile and Bradley L. Pentelute

Chem. Sci., 2023, 14, 12484
DOI: 10.1039/D3SC02782A

Drugging the undruggable: a computational chemist's view of KRASG12C

Michael S. Bodnarchuk, Doyle J. Cassar, Jason G. Kettle, Graeme Robb and Richard A. Ward

RSC Med. Chem., 2021, 12, 609
DOI: 10.1039/D1MD00055A

A Versatile Strategy to Manipulate and Probe Native Carbonic Anhydrases In Cellulo Utilizing Two-Step Ligand-Directed Functionalization

Wai-Seng Io and Tsung-Shing Andrew Wang

ACS Chem. Biol., 2023, 18, 1208
DOI: 10.1021/acschembio.3c00102

Innovative design and potential applications of covalent strategy in drug discovery

Tianyong Tang, Jiaxiang Luo, Dan Zhang, Yang Lu, Wen Liao and Jifa Zhang

European Journal of Medicinal Chemistry, 2025, 284, 117202
DOI: 10.1016/j.ejmech.2024.117202

CovBinderInPDB: A Structure-Based Covalent Binder Database

Xiao-Kang Guo and Yingkai Zhang

J. Chem. Inf. Model., 2022, 62, 6057
DOI: 10.1021/acs.jcim.2c01216

TopCysteineDB: A Cysteinome-wide Database Integrating Structural and Chemoproteomics Data for Cysteine Ligandability Prediction

Michele Bonus, Julian Greb, Jaimeen D. Majmudar, Markus Boehm, Magdalena Korczynska, Azadeh Nazemi, Alan M. Mathiowetz and Holger Gohlke

Journal of Molecular Biology, 2025, 437, 169196
DOI: 10.1016/j.jmb.2025.169196

How the Local Environment of Functional Sites Regulates Protein Function

Karine Mazmanian, Karen Sargsyan and Carmay Lim

J. Am. Chem. Soc., 2020, 142, 9861
DOI: 10.1021/jacs.0c02430

Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions

Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, Ashraf N. Abdalla, Bahaa G.M. Youssif, Nashwa A. Ibrahim, Mohammed Gamal, Hany A.M. El-Sherief, Maha M. Abdel-Fattah, Ahmed A. Hefny, Ahmed H. Abdelazeem and Ahmed M. Gouda

European Journal of Medicinal Chemistry, 2024, 277, 116704
DOI: 10.1016/j.ejmech.2024.116704

Therapeutic peptides: current applications and future directions

Lei Wang, Nanxi Wang, Wenping Zhang, Xurui Cheng, Zhibin Yan, Gang Shao, Xi Wang, Rui Wang and Caiyun Fu

Sig Transduct Target Ther, 2022, 7
DOI: 10.1038/s41392-022-00904-4

Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small-cell Lung Cancer

Junping Pei, Guan Wang, Aoxue Wang, Chengyong Wu, Xiaoli Pan, Wen Shuai, Faqian Bu, Yumeng Zhu, Yuxi Wang, Liang Ouyang and Weimin Li

J. Med. Chem., 2023, 66, 5719
DOI: 10.1021/acs.jmedchem.3c00027

Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics

Giulia Alboreggia, Parima Udompholkul, Emma L. Atienza, Kendall Muzzarelli, Zahra Assar and Maurizio Pellecchia

J. Med. Chem., 2024, 67, 20214
DOI: 10.1021/acs.jmedchem.4c01541

Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase

Umberto Maria Battisti, Chunxia Gao, Oscar Nilsson, Fady Akladios, Aleksei Lulla, Agnieszka Bogucka, Amalyn Nain‐Perez, Liliana Håversen, Woonghee Kim, Jan Boren, Marko Hyvönen, Mathias Uhlen, Adil Mardinoglu and Morten Grøtli

ChemBioChem, 2023, 24
DOI: 10.1002/cbic.202200339

Discovery and development of quinazoline compounds as irreversible pan-fibroblast growth factor receptor inhibitors with potent antitumor activities

Shihe Hu, Cuihua Jiang, Meng Gao, Dongjian Zhang, Nan Yao, Jian Zhang and Qiaomei Jin

Journal of Molecular Structure, 2024, 1299, 137224
DOI: 10.1016/j.molstruc.2023.137224

Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells

Gongli Cai, Yishu Bao, Qingyun Li, Pang-Hung Hsu, Jiang Xia and Jacky Chi Ki Ngo

Commun Chem, 2024, 7
DOI: 10.1038/s42004-024-01230-2

Acetylation of the Catalytic Lysine Inhibits Kinase Activity in PI3Kδ

Julie C. L. Fournier, John P. Evans, Francesca Zappacosta, Daniel A. Thomas, Vipulkumar K. Patel, Gemma V. White, Sebastien Campos and Nicholas C. O. Tomkinson

ACS Chem. Biol., 2021, 16, 1644
DOI: 10.1021/acschembio.1c00225

Revealing a Decisive Role for Secondary Coordination Sphere Nucleophiles on Methane Activation

Mary E. Anderson, Benoît Braïda, Philippe C. Hiberty and Thomas R. Cundari

J. Am. Chem. Soc., 2020, 142, 3125
DOI: 10.1021/jacs.9b12644

Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship

Lin Wang, Zhengjie Zhang, Dongke Yu, Liuqing Yang, Ling Li, Yuxin He and Jianyou Shi

Bioorganic Chemistry, 2023, 138, 106577
DOI: 10.1016/j.bioorg.2023.106577

In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity

Jingben Zheng, Xiaoye Li, Ao He, Yu Zhang, Yuebo Yang, Meng Dang, Qiang Li, Yongbin Mou and Heng Dong

Journal of Controlled Release, 2025, 385, 113984
DOI: 10.1016/j.jconrel.2025.113984

Advanced technologies for screening and identifying covalent inhibitors

Yaolin Guo, Wen shuai, Aiping Tong and Yuxi Wang

TrAC Trends in Analytical Chemistry, 2024, 178, 117833
DOI: 10.1016/j.trac.2024.117833

CovaDOTS: In Silico Chemistry-Driven Tool to Design Covalent Inhibitors Using a Linking Strategy

Laurent Hoffer, Magali Saez-Ayala, Dragos Horvath, Alexandre Varnek, Xavier Morelli and Philippe Roche

J. Chem. Inf. Model., 2019, 59, 1472
DOI: 10.1021/acs.jcim.8b00960

Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach

Lin Du, Samantha S. Yee, Karthik Ramachandran and April L. Risinger

Nat Commun, 2020, 11
DOI: 10.1038/s41467-019-14277-w

Covalent inhibitors of EZH2: Design, synthesis and evaluation

Qiangsheng Zhang, Xinyi Chen, Xi Hu, Xianjie Duan, Guoquan Wan, Lu Li, Qiang Feng, Yiqian Zhang, Ningyu Wang and Luoting Yu

Biomedicine & Pharmacotherapy, 2022, 147, 112617
DOI: 10.1016/j.biopha.2022.112617

Inhibition of autophagy potentiates the cytotoxicity of the irreversible FGFR1-4 inhibitor FIIN-2 on lung adenocarcinoma

Xiuqin Jia, Ming Xin, Juanjuan Xu, Xindong Xiang, Xuan Li, Yuhan Jiao, Lulin Wang, Jingjing Jiang, Feng Pang, Xianzhen Zhang and Jian Zhang

Cell Death Dis, 2022, 13
DOI: 10.1038/s41419-022-05201-0

Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease

Kailash Jangid, Bharti Devi, Ashrulochan Sahoo, Vijay Kumar, Ashish Ranjan Dwivedi, Suresh Thareja, Rajnish Kumar and Vinod Kumar

Journal of Biomolecular Structure and Dynamics, 2024, 42, 509
DOI: 10.1080/07391102.2023.2201838

Thiol Reactivity of N-Aryl α-Methylene-γ-lactams: A Reactive Group for Targeted Covalent Inhibitor Design

Tuğçe G. Erbay, Daniel P. Dempe, Bhaskar Godugu, Peng Liu and Kay M. Brummond

J. Org. Chem., 2021, 86, 11926
DOI: 10.1021/acs.joc.1c01335

Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1

Raju Dash, Md. Arifuzzaman, Sarmistha Mitra, Md. Abdul Hannan, Nurul Absar and S.M. Zahid Hosen

CPD, 2019, 25, 1059
DOI: 10.2174/1381612825666190527095510

Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities

Caitlin A. Nichols, William J. Gibson, Meredith S. Brown, Jack A. Kosmicki, John P. Busanovich, Hope Wei, Laura M. Urbanski, Naomi Curimjee, Ashton C. Berger, Galen F. Gao, Andrew D. Cherniack, Sirano Dhe-Paganon, Brenton R. Paolella and Rameen Beroukhim

Nat Commun, 2020, 11
DOI: 10.1038/s41467-020-16399-y

Identification of Highly Selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors by a Covalent Fragment-Based Approach

Fubao Huang, Hangchen Hu, Kai Wang, Chengyuan Peng, Wenwei Xu, Yu Zhang, Jing Gao, Yishen Liu, Hu Zhou, Ruimin Huang, Minjun Li, Jianhua Shen and Yechun Xu

J. Med. Chem., 2020, 63, 7052
DOI: 10.1021/acs.jmedchem.0c00372

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

Matthias Gehringer and Stefan A. Laufer

J. Med. Chem., 2019, 62, 5673
DOI: 10.1021/acs.jmedchem.8b01153

Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres

Patrick Müller, Collin Zimmer, Ariane Frey, Gideon Holzmann, Annabelle Carolin Weldert and Tanja Schirmeister

IJMS, 2024, 25, 1375
DOI: 10.3390/ijms25031375

Covalent inactivation of Mycobacterium thermoresistibile inosine-5′-monophosphate dehydrogenase (IMPDH)

Ana Trapero, Angela Pacitto, Daniel Shiu-Hin Chan, Chris Abell, Tom L. Blundell, David B. Ascher and Anthony G. Coyne

Bioorganic & Medicinal Chemistry Letters, 2020, 30, 126792
DOI: 10.1016/j.bmcl.2019.126792

Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity

Fengling Liu, Chunxi Liu, Qipeng Chai, Chunlong Zhao, Hongwei Meng, Xia Xue, Tso-pang Yao and Yingjie Zhang

J. Med. Chem., 2023, 66, 10080
DOI: 10.1021/acs.jmedchem.3c00977

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery

Kirsten McAulay, Alan Bilsland and Marta Bon

Pharmaceuticals, 2022, 15, 1366
DOI: 10.3390/ph15111366

TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure

Maria Kalyukina, Yuliana Yosaatmadja, Martin J. Middleditch, Adam V. Patterson, Jeff B. Smaill and Christopher J. Squire

ChemMedChem, 2019, 14, 494
DOI: 10.1002/cmdc.201800719

Covalent drug – An emerging framework for targeted drug development

Ritesh P. Bhole, Govinda O. Joshi, Harshad S. Kapare, Rupesh V. Chikhale and Somdatta Chaudhari

Results in Chemistry, 2024, 8, 101615
DOI: 10.1016/j.rechem.2024.101615

Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein

Parima Udompholkul, Carlo Baggio, Luca Gambini, Giulia Alboreggia and Maurizio Pellecchia

J. Med. Chem., 2021, 64, 16147
DOI: 10.1021/acs.jmedchem.1c01459

Synthesis and Biological Evaluations of Electrophilic Steroids Inspired by the Taccalonolides

Nicholas A. Clanton, Shayne D. Hastings, Griffin B. Foultz, Julie A. Contreras, Samantha S. Yee, Hadi D. Arman, April L. Risinger and Doug E. Frantz

ACS Med. Chem. Lett., 2020, 11, 2534
DOI: 10.1021/acsmedchemlett.0c00534

Discovery of Pteridine-7(8H)-one Derivatives as Potent and Selective Inhibitors of Bruton’s Tyrosine Kinase (BTK)

Dou Dou, Yanyan Diao, Wenjie Sha, Rongrong Su, Linjiang Tong, Wenjie Li, Limin Leng, Lijuan Xie, Zhixiao Yu, Haoming Song, Zihao Shen, Lili Zhu, Zhenjiang Zhao, Hua Xie, Zhuo Chen, Honglin Li and Yufang Xu

J. Med. Chem., 2022, 65, 2694
DOI: 10.1021/acs.jmedchem.1c02208

Radical scavenging and anti-inflammatory activities of (hetero)arylethenesulfonyl fluorides: Synthesis and structure-activity relationship (SAR) and QSAR studies

Ying Jiang, K.P. Rakesh, Njud S. Alharbi, H.K. Vivek, H.M. Manukumar, Y.H.E. Mohammed and Hua-Li Qin

Bioorganic Chemistry, 2019, 89, 103015
DOI: 10.1016/j.bioorg.2019.103015

Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects

Yunyuan Huang, Lin Wei, Xinya Han, Haifeng Chen, Yanliang Ren, Yanhong Xu, Rongrong Song, Li Rao, Chen Su, Chao Peng, Lingling Feng and Jian Wan

European Journal of Medicinal Chemistry, 2019, 184, 111749
DOI: 10.1016/j.ejmech.2019.111749

Covalent Small Molecules as Enabling Platforms for Drug Discovery

Samuel E. Dalton and Sebastien Campos

ChemBioChem, 2020, 21, 1080
DOI: 10.1002/cbic.201900674

Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines

Katharina Klose, Eva‐Maria Packeiser, José‐Luis Granados‐Soler, Marion Hewicker‐Trautwein, Hugo Murua Escobar and Ingo Nolte

Vet Comparative Oncology, 2022, 20, 641
DOI: 10.1111/vco.12817

What coronavirus 3C‐like protease tells us: From structure, substrate selectivity, to inhibitor design

Muya Xiong, Haixia Su, Wenfeng Zhao, Hang Xie, Qiang Shao and Yechun Xu

Medicinal Research Reviews, 2021, 41, 1965
DOI: 10.1002/med.21783

CovPDB: a high-resolution coverage of the covalent protein–ligand interactome

Mingjie Gao, Aurélien F A Moumbock, Ammar Qaseem, Qianqing Xu and Stefan Günther

Nucleic Acids Research, 2022, 50, D445
DOI: 10.1093/nar/gkab868

Toward Atomistic Modeling of Irreversible Covalent Inhibitor Binding Kinetics

Haoyu S. Yu, Cen Gao, Dmitry Lupyan, Yujie Wu, Takayuki Kimura, Chuanjie Wu, Leif Jacobson, Edward Harder, Robert Abel and Lingle Wang

J. Chem. Inf. Model., 2019, 59, 3955
DOI: 10.1021/acs.jcim.9b00268

Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation

Tinghu Zhang, John M. Hatcher, Mingxing Teng, Nathanael S. Gray and Milka Kostic

Cell Chemical Biology, 2019, 26, 1486
DOI: 10.1016/j.chembiol.2019.09.012

Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents

Kemel Arafet, Laura Scalvini, Francesca Galvani, Sergio Martí, Vicent Moliner, Marco Mor and Alessio Lodola

J. Chem. Inf. Model., 2023, 63, 1301
DOI: 10.1021/acs.jcim.2c01586

Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review

Muhammad Salman Hameed, Hongxuan Cao, Li Guo, Lei Zeng and Yanliang Ren

European Journal of Medicinal Chemistry Reports, 2024, 12, 100217
DOI: 10.1016/j.ejmcr.2024.100217

An Enzyme-Catalyzed Polymerization Strategy Disrupts Protein Homeostasis for Improved Tumor Therapy

Yinsheng Xu, Yingjin Zhang, Benli Song, Yixuan Liu, Yi Hao, Duan Zhongyu, Zeng-Ying Qiao and Hao Wang

Biomacromolecules, 2025
DOI: 10.1021/acs.biomac.5c00928

An update on the discovery and development of reversible covalent inhibitors

Faridoon, Raymond Ng, Guiping Zhang and Jie Jack Li

Med Chem Res, 2023, 32, 1039
DOI: 10.1007/s00044-023-03065-3

Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX

Aivaras Vaškevičius, Denis Baronas, Janis Leitans, Agnė Kvietkauskaitė, Audronė Rukšėnaitė, Elena Manakova, Zigmantas Toleikis, Algirdas Kaupinis, Andris Kazaks, Marius Gedgaudas, Aurelija Mickevičiūtė, Vaida Juozapaitienė, Helgi B Schiöth, Kristaps Jaudzems, Mindaugas Valius, Kaspars Tars, Saulius Gražulis, Franz-Josef Meyer-Almes, Jurgita Matulienė, Asta Zubrienė, Virginija Dudutienė and Daumantas Matulis

eLife, 2024, 13
DOI: 10.7554/eLife.101401.3

Affinity and Selectivity Assessment of Covalent Inhibitors by Free Energy Calculations

Levente M. Mihalovits, György G. Ferenczy and György M. Keserű

J. Chem. Inf. Model., 2020, 60, 6579
DOI: 10.1021/acs.jcim.0c00834

Discovery of Highly-Functionalized 5-Hydroxy- 2H-Pyrrol-2-Ones that Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

Miguel Guerra-Rodríguez, Priscila López-Rojas, Ángel Amesty, Haidée Aranda-Tavío, Yeray Brito-Casillas, Ana Estévez-Braun, Leandro Fernandez-Perez, Borja Guerra and Carlota Recio

SSRN Journal, 2022
DOI: 10.2139/ssrn.4197933

Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency

Stepan K. Krymov, Diana I. Salnikova, Lyubov G. Dezhenkova, Fedor B. Bogdanov, Alexander A. Korlyukov, Alexander M. Scherbakov and Andrey E. Shchekotikhin

Pharmaceuticals, 2023, 17, 32
DOI: 10.3390/ph17010032

Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis

Wuqiang Wen, Hongxuan Cao, Yunyuan Huang, Jie Tu, Chen Wan, Jian Wan, Xinya Han, Han Chen, Jiaqi Liu, Li Rao, Chen Su, Chao Peng, Chunquan Sheng and Yanliang Ren

J. Med. Chem., 2022, 65, 2656
DOI: 10.1021/acs.jmedchem.1c02102

MD-Based Assessment of Covalent Inhibitors in Noncovalent Association Complexes: Learning from Cathepsin K as a Test Case

Erik Endres, Natalia Yuan Chen and Christoph Sotriffer

J. Chem. Inf. Model., 2023, 63, 3186
DOI: 10.1021/acs.jcim.3c00061

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery

Yutong Wang, Shiyu Luo, Hongbao Sun, Shuai Huang, Lianhai Shan and Jifa Zhang

Drug Discovery Today, 2025, 30, 104347
DOI: 10.1016/j.drudis.2025.104347

Species-specific lipophilicities of fluorinated diketones in complex equilibria systems and their potential as multifaceted reversible covalent warheads

Ishay Columbus, Lee Ghindes-Azaria, Ido Michael Herzog, Eliav Blum, Galit Parvari, Yoav Eichen, Yoram Cohen, Eytan Gershonov, Eyal Drug, Sigal Saphier, Shlomi Elias, Boris Smolkin and Yossi Zafrani

Commun Chem, 2023, 6
DOI: 10.1038/s42004-023-01004-2

ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries

Lulu Jiang, Sixiu Liu, Xinglong Jia, Qinting Gong, Xin Wen, Weiwei Lu, Jintong Yang, Xinyuan Wu, Xuan Wang, Yanrui Suo, Yilin Li, Motonari Uesugi, Zhi-bei Qu, Minjia Tan, Xiaojie Lu and Lu Zhou

J. Am. Chem. Soc., 2023, 145, 25283
DOI: 10.1021/jacs.3c08852

Recent Progresses of Peptide Fluorescent Probes for Protein Analysis in Living Cells

Xia Wu, Hao Zhang, Mingxuan Li, Fan Xia and Xiaoding Lou

ACS Materials Lett., 2025, 7, 2524
DOI: 10.1021/acsmaterialslett.4c02671

From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions

Seong Ho Hong, Thu Nguyen, Joseph F. Ongkingco, Alex Nazzaro and Paramjit S. Arora

Chem. Rev., 2025, 125, 6819
DOI: 10.1021/acs.chemrev.5c00046

Thiol Reactivity of N-Aryl α-Methylene-γ-lactams: Influence of the Guaianolide Structure

Daniel P. Dempe, Chong-Lei Ji, Peng Liu and Kay M. Brummond

J. Org. Chem., 2022, 87, 11204
DOI: 10.1021/acs.joc.2c01530

BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides

Markus R. Hermann, Christofer S. Tautermann, Peter Sieger, Marc A. Grundl and Alexander Weber

Pharmaceuticals, 2023, 16, 116
DOI: 10.3390/ph16010116

The expanding repertoire of covalent warheads for drug discovery

Namrashee V. Mehta and Mariam S. Degani

Drug Discovery Today, 2023, 28, 103799
DOI: 10.1016/j.drudis.2023.103799

Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp

Guillaume Compain, Clément Monsarrat, Julie Blagojevic, Karl Brillet, Philippe Dumas, Philippe Hammann, Lauriane Kuhn, Isabelle Martiel, Sylvain Engilberge, Vincent Oliéric, Philippe Wolff, Dominique Y. Burnouf, Jérôme Wagner and Gilles Guichard

JACS Au, 2024, 4, 432
DOI: 10.1021/jacsau.3c00572

The long and short non-coding RNAs modulating EZH2 signaling in cancer

Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh and Alan Prem Kumar

J Hematol Oncol, 2022, 15
DOI: 10.1186/s13045-022-01235-1

Technologies for Direct Detection of Covalent Protein–Drug Adducts

Elma Mons, Robbert Q. Kim and Monique P. C. Mulder

Pharmaceuticals, 2023, 16, 547
DOI: 10.3390/ph16040547

Emerging drug design strategies in anti-influenza drug discovery

Chuanfeng Liu, Lide Hu, Guanyu Dong, Ying Zhang, Edeildo Ferreira da Silva-Júnior, Xinyong Liu, Luis Menéndez-Arias and Peng Zhan

Acta Pharmaceutica Sinica B, 2023, 13, 4715
DOI: 10.1016/j.apsb.2023.08.010

Development of a High-Throughput Affinity Mass Spectrometry (AMS) Platform Using Laser Diode Thermal Desorption Ionization Coupled to Mass Spectrometry (LDTD-MS)

Aniruddha Sahasrabuddhe, Dylan Oakley, Kui Chen and John D. McCarter

SLAS Discovery, 2021, 26, 230
DOI: 10.1177/2472555220979596

Recent Advances in Covalent Drug Discovery

Daniel Schaefer and Xinlai Cheng

Pharmaceuticals, 2023, 16, 663
DOI: 10.3390/ph16050663

Characterising covalent warhead reactivity

James S. Martin, Claire J. MacKenzie, Daniel Fletcher and Ian H. Gilbert

Bioorganic & Medicinal Chemistry, 2019, 27, 2066
DOI: 10.1016/j.bmc.2019.04.002

CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors

Hongyan Du, Junbo Gao, Gaoqi Weng, Junjie Ding, Xin Chai, Jinping Pang, Yu Kang, Dan Li, Dongsheng Cao and Tingjun Hou

Nucleic Acids Research, 2021, 49, D1122
DOI: 10.1093/nar/gkaa876

Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase

Yitian Zhao, Min Zhang, Xudong Hou, Jiaxin Han, Xiaoya Qin, Yun Yang, Yunqing Song, Zhikai Liu, Yong Zhang, Zhijian Xu, Qi Jia, Yiming Li, Kaixian Chen, Bo Li, Weiliang Zhu and Guangbo Ge

Bioorganic & Medicinal Chemistry, 2023, 91, 117413
DOI: 10.1016/j.bmc.2023.117413

Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance

Kun Zhang, Yu‐Jie Zhang, Min Li, Christophe Pannecouque, Erik De Clercq, Shuai Wang and Fen‐Er Chen

Medicinal Research Reviews, 2025, 45, 426
DOI: 10.1002/med.22080

Covalent vs. Non‐Covalent Inhibition: Tackling Drug Resistance in EGFR – A Thorough Dynamic Perspective

Farideh Badichi Akher, Abdolkarim Farrokhzadeh and Mahmoud E. S. Soliman

Chemistry & Biodiversity, 2019, 16
DOI: 10.1002/cbdv.201800518

Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces

Alberto M. Dos Santos, Amanda Ruslana Santana Oliveira, Clauber H. S. da Costa, Peter W. Kenny, Carlos A. Montanari, Jaldyr de Jesus G. Varela and Jerônimo Lameira

J. Chem. Inf. Model., 2022, 62, 4083
DOI: 10.1021/acs.jcim.2c00466

An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase

Islam Al-Khawaldeh, Mohammed J. Al Yasiri, Gregory G. Aldred, Christine Basmadjian, Cinzia Bordoni, Suzannah J. Harnor, Amy B. Heptinstall, Stephen J. Hobson, Claire E. Jennings, Shaimaa Khalifa, Honorine Lebraud, Mathew P. Martin, Duncan C. Miller, Harry J. Shrives, João V. de Souza, Hannah L. Stewart, Max Temple, Huw D. Thomas, Jane Totobenazara, Julie A. Tucker, Susan J. Tudhope, Lan Z. Wang, Agnieszka K. Bronowska, Céline Cano, Jane A. Endicott, Bernard T. Golding, Ian R. Hardcastle, Ian Hickson, Stephen R. Wedge, Elaine Willmore, Martin E. M. Noble and Michael J. Waring

J. Med. Chem., 2021, 64, 10001
DOI: 10.1021/acs.jmedchem.0c01249

Robust Covalent Aptamer Strategy Enables Sensitive Detection and Enhanced Inhibition of SARS-CoV-2 Proteins

Dan Wang, Jing Zhang, Zhiyong huang, Yuhang Yang, Ting Fu, Yu Yang, Yifan Lyu, Jianhui Jiang, Liping Qiu, Zehui Cao, Xiaobing Zhang, Qimin You, Yuankui Lin, Zilong Zhao and Weihong Tan

ACS Cent. Sci., 2023, 9, 72
DOI: 10.1021/acscentsci.2c01263

The Structure–property Relationships of Clinically Approved Protein Kinase Inhibitors

Kihang Choi

CMC, 2023, 30, 2518
DOI: 10.2174/0929867329666220822123552

Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2

Foteini-Nafsika Damaskinaki, Luis A. Moran, Angel Garcia, Barrie Kellam and Steve P. Watson

Platelets, 2021, 32, 744
DOI: 10.1080/09537104.2020.1863939

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with α-Substituent Electrophiles Targeting Cysteine

Yangcheng Ai, Zichao Yang, Zilong Yang, Shanhe Wan, Chunhui Huang, Chuan Huang, Mingxia Li, Zhonghuang Li, Jiajie Zhang and Tingting Zhang

J. Chem. Inf. Model., 2023, 63, 493
DOI: 10.1021/acs.jcim.2c00458

Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease

Yuying Ma, Linfeng Li, Shuai He, Chengyou Shang, Yang Sun, Ning Liu, Thomas D. Meek, Yaxin Wang and Luqing Shang

J. Med. Chem., 2019, 62, 6146
DOI: 10.1021/acs.jmedchem.9b00387

Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2

Deepesh Kumar Patel, Harish Kumar and M. Elizabeth Sobhia

Computational Biology and Chemistry, 2024, 112, 108132
DOI: 10.1016/j.compbiolchem.2024.108132

Genetically encoding latent bioreactive amino acids and the development of covalent protein drugs

Nanxi Wang and Lei Wang

Current Opinion in Chemical Biology, 2022, 66, 102106
DOI: 10.1016/j.cbpa.2021.102106

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, Wenbo Wang, Xiangyi Jiang, Ruifang Jia, Christophe Pannecouque, Erik De Clercq, Dongwei Kang, Peng Zhan and Xinyong Liu

J. Med. Chem., 2022, 65, 3729
DOI: 10.1021/acs.jmedchem.1c01758

Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics

Rameshwar S. Cheke and Prashant S. Kharkar

Drug Development Research, 2024, 85
DOI: 10.1002/ddr.22132

Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, Richard A. Noble, Sara Pintar, Lan Z. Wang, Shangze Xu, Andrew Lister, Richard A. Ward, Agnieszka K. Bronowska, Martin E. M. Noble, Hannah L. Stewart and Michael J. Waring

Commun Chem, 2025, 8
DOI: 10.1038/s42004-025-01501-6

Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?

Hui Tao, Bo Yang, Atena Farhangian, Ke Xu, Tongtong Li, Zhong-Yin Zhang and Jianing Li

J. Med. Chem., 2025, 68, 4040
DOI: 10.1021/acs.jmedchem.4c02760

Machine learning-accelerated quantum mechanics-based atomistic simulations for industrial applications

Tobias Morawietz and Nongnuch Artrith

J Comput Aided Mol Des, 2021, 35, 557
DOI: 10.1007/s10822-020-00346-6

Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling

Chen Chen, Tianyu Zhu, Xiaoqin Liu, Dongrong Zhu, Yi Zhang, Sifang Wu, Chao Han, Hao Zhang, Jianguang Luo and Lingyi Kong

Acta Pharmaceutica Sinica B, 2022, 12, 246
DOI: 10.1016/j.apsb.2021.06.008

Novel 6-amino-1,3,5-triazine derivatives as potent BTK inhibitors: structure-activity relationship (SAR) analysis and preliminary mechanism investigation

Maoxu Xiao, Meiqi Zhu, Shuangjie Wu, Luyu Ma, Lin Qi, Si Ha, Shuangshuang Xiong, Mingqi Chen, Deying Chen, Guoshun Luo and Hua Xiang

Bioorganic Chemistry, 2023, 130, 106263
DOI: 10.1016/j.bioorg.2022.106263

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

Brian C. Sanders, Suman Pokhrel, Audrey D. Labbe, Irimpan I. Mathews, Connor J. Cooper, Russell B. Davidson, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Hugh O’Neill, Manat Kaur, Jurgen G. Schmidt, Walter Reichard, Surekha Surendranathan, Jyothi Parvathareddy, Lexi Phillips, Christopher Rainville, David E. Sterner, Desigan Kumaran, Babak Andi, Gyorgy Babnigg, Nigel W. Moriarty, Paul D. Adams, Andrzej Joachimiak, Brett L. Hurst, Suresh Kumar, Tauseef R. Butt, Colleen B. Jonsson, Lori Ferrins, Soichi Wakatsuki, Stephanie Galanie, Martha S. Head and Jerry M. Parks

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-37254-w

Reinvent Aliphatic Arsenicals as Reversible Covalent Warheads toward Targeted Kinase Inhibition and Non-acute Promyelocytic Leukemia Cancer Treatment

Yang Zhao, Xinyue Zhao, Lewei Duan, Ruxue Hou, Yuxin Gu, Zhen Liu, Jianbin Chen, Feizhen Wu, Limin Yang, X. Chris Le, Qiuquan Wang and Xiaowen Yan

J. Med. Chem., 2024, 67, 5458
DOI: 10.1021/acs.jmedchem.3c02076

Identification and Characterization of ACP-5862, the Major Circulating Active Metabolite of Acalabrutinib: Both Are Potent and Selective Covalent Bruton Tyrosine Kinase Inhibitors

Terry Podoll, Paul G. Pearson, Allard Kaptein, Jerry Evarts, Gerjan de Bruin, Maaike Emmelot-van Hoek, Anouk de Jong, Bart van Lith, Hao Sun, Stephen Byard, Adrian Fretland, Niels Hoogenboom, Tjeerd Barf and J. Greg Slatter

The Journal of Pharmacology and Experimental Therapeutics, 2023, 384, 173
DOI: 10.1124/jpet.122.001116

Reactivities of acrylamide warheads toward cysteine targets: a QM/ML approach to covalent inhibitor design

Aaron D. Danilack, Callum J. Dickson, Cihan Soylu, Mike Fortunato, Stephane Rodde, Hagen Munkler, Viktor Hornak and Jose S. Duca

J Comput Aided Mol Des, 2024, 38
DOI: 10.1007/s10822-024-00560-6

The role of quantum chemistry in covalent inhibitor design

Levente M. Mihalovits, György G. Ferenczy and György M. Keserű

Int J of Quantum Chemistry, 2022, 122
DOI: 10.1002/qua.26768

Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead

Katarina Grabrijan, Martina Hrast, Matic Proj, Ana Dolšak, Irena Zdovc, Tímea Imre, László Petri, Péter Ábrányi-Balogh, György M. Keserű and Stanislav Gobec

European Journal of Medicinal Chemistry, 2022, 243, 114752
DOI: 10.1016/j.ejmech.2022.114752

Toward the identification of ZDHHC enzymes required for palmitoylation of viral protein as potential drug targets

Mohamed Rasheed Gadalla and Michael Veit

Expert Opinion on Drug Discovery, 2020, 15, 159
DOI: 10.1080/17460441.2020.1696306

The design and development of covalent protein-protein interaction inhibitors for cancer treatment

Sha-Sha Cheng, Guan-Jun Yang, Wanhe Wang, Chung-Hang Leung and Dik-Lung Ma

J Hematol Oncol, 2020, 13
DOI: 10.1186/s13045-020-00850-0

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

Hossam Nada, Yongseok Choi, Sungdo Kim, Kwon Su Jeong, Nicholas A. Meanwell and Kyeong Lee

Sig Transduct Target Ther, 2024, 9
DOI: 10.1038/s41392-024-02036-3

The Ascension of Targeted Covalent Inhibitors

Juswinder Singh

J. Med. Chem., 2022, 65, 5886
DOI: 10.1021/acs.jmedchem.1c02134

Relationship among structure, cytotoxicity, and Michael acceptor reactivity of quinocidin

Yu Nakagawa, Yuki Sawaki, Wataru Miyanishi, Sayako Shimomura, Takahiro Shibata and Makoto Ojika

Bioorganic & Medicinal Chemistry, 2020, 28, 115308
DOI: 10.1016/j.bmc.2020.115308

A patent review of CYP3A4 inhibitors (2018 – present)

Dong-Zhu Tu, Xue-Yan Hu, Jing-Xuan Lei, Shu-Yan Liu, Zhang-Ping Xiao, Ling Yang and Guang-Bo Ge

Expert Opinion on Therapeutic Patents, 2025, 35, 503
DOI: 10.1080/13543776.2025.2470294

Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy

Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, Salomé Catalina Vilchez Larrea, Guillermo Daniel Alonso, Rafaela Salgado Ferreira, Wim Dehaen and Mario Alfredo Quevedo

ACS Med. Chem. Lett., 2025, 16, 464
DOI: 10.1021/acsmedchemlett.4c00631

Application of the Rumsfeld matrix to anticancer natural product target discovery

Christian Bailly

Pharmacological Research - Reports, 2024, 2, 100023
DOI: 10.1016/j.prerep.2024.100023

Discovery and optimization of covalent Bcl-xL antagonists

Herschel Mukherjee, Nancy Su, Matthew A. Belmonte, David Hargreaves, Joe Patel, Sharon Tentarelli, Brian Aquila and Neil P. Grimster

Bioorganic & Medicinal Chemistry Letters, 2019, 29, 126682
DOI: 10.1016/j.bmcl.2019.126682

Design, synthesis, and biological evaluation of novel covalent inhibitors targeting focal adhesion kinase

Tao Chen, Yan Liu, Mingsong Shi, Minghai Tang, Wenting Si, Xue Yuan, Yi Wen and Lijuan Chen

Bioorganic & Medicinal Chemistry Letters, 2021, 54, 128433
DOI: 10.1016/j.bmcl.2021.128433

A Sulfonium Triggered Thiol-yne Reaction for Cysteine Modification

Zhanfeng Hou, Dongyuan Wang, Yang Li, Rongtong Zhao, Chuan Wan, Yue Ma, Chenshan Lian, Feng Yin and Zigang Li

J. Org. Chem., 2020, 85, 1698
DOI: 10.1021/acs.joc.9b02505

Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors

Bingbing Li, Deqin Rong and Yuanxiang Wang

CTMC, 2019, 19, 1872
DOI: 10.2174/1568026619666191011163410

Understanding Cysteine Chemistry Using Conventional and Serial X-ray Protein Crystallography

Nathan Smith and Mark A. Wilson

Crystals, 2022, 12, 1671
DOI: 10.3390/cryst12111671

Assembly‐Glued Ligands and Warheads for Hypoxia‐Activatable Supramolecular Covalent Inhibitors

Binbin Hu, Weida Qin, Yushi Wang, Zeyu Zhang, Ninglin Chen, Hongbo Wang, Gongyu Li, Yang Shi and Zhilin Yu

Adv Funct Materials, 2024, 34
DOI: 10.1002/adfm.202411179

Covalent fragment libraries in drug discovery

Aaron Keeley, László Petri, Péter Ábrányi-Balogh and György M. Keserű

Drug Discovery Today, 2020, 25, 983
DOI: 10.1016/j.drudis.2020.03.016

Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues

Luca Gambini, Carlo Baggio, Parima Udompholkul, Jennifer Jossart, Ahmed F. Salem, J. Jefferson P. Perry and Maurizio Pellecchia

J. Med. Chem., 2019, 62, 5616
DOI: 10.1021/acs.jmedchem.9b00561

Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor

Yazhou Wang, Jinxin Liu, Yihong Zhang, Jichen Zhao, Chao Wang, Hui Cui, Fanye Meng, Alex Aliper, Tao Liang, Feng Yan, Feng Ren, Jiong Lan, Qiang Lu, Fusheng Zhou, Xin Cai, Xiao Ding and Alex Zhavoronkov

J. Med. Chem., 2025, 68, 13887
DOI: 10.1021/acs.jmedchem.5c00928

The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development

Weizhu Yan, Yanhui Zheng, Chao Dou, Guixiang Zhang, Toufic Arnaout and Wei Cheng

Mol Biomed, 2022, 3
DOI: 10.1186/s43556-022-00106-y

Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy

Carlo Baggio, Parima Udompholkul, Luca Gambini, Ahmed F. Salem, Jennifer Jossart, J. Jefferson P. Perry and Maurizio Pellecchia

J. Med. Chem., 2019, 62, 9188
DOI: 10.1021/acs.jmedchem.9b01108

Mechanism of activation and the rewired network: New drug design concepts

Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, Chung‐Jung Tsai, Bengi Ruken Yavuz, Nurcan Tuncbag and Hyunbum Jang

Medicinal Research Reviews, 2022, 42, 770
DOI: 10.1002/med.21863

An enzyme activity-based workflow for the identification and characterization of covalent inhibitors

Buyun Tang, Tatiana Gladysheva and Paul Lang

SLAS Discovery, 2025, 35, 100250
DOI: 10.1016/j.slasd.2025.100250

Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma

Bo Li, Yongliang Li, Céline Tomkiewicz-Raulet, Pascal Dao, Daniel Lietha, Expédite Yen-Pon, Zhiyun Du, Xavier Coumoul, Christiane Garbay, Mélanie Etheve-Quelquejeu and Huixiong Chen

J. Med. Chem., 2020, 63, 12707
DOI: 10.1021/acs.jmedchem.0c01059

Development of covalent inhibitors: Principle, design, and application in cancer

Lang Zheng, Yang Li, Defa Wu, Huan Xiao, Shilong Zheng, Guan Wang and Qiu Sun

MedComm – Oncology, 2023, 2
DOI: 10.1002/mog2.56

Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery

Md Nazmul Hasan, Manisha Ray and Arjun Saha

J. Phys. Chem. B, 2023, 127, 9663
DOI: 10.1021/acs.jpcb.3c04710

Highly stereoselective organocatalytic synthesis of pyrrolidinyl spirooxindoles containing halogenated contiguous quaternary carbon stereocenters

Fei-Yu Chen, Li Xiang, Gu Zhan, Hong Liu, Bin Kang, Shu-Cang Zhang, Cheng Peng and Bo Han

Tetrahedron Letters, 2020, 61, 151806
DOI: 10.1016/j.tetlet.2020.151806

Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches

Natalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, Katarzyna Kuncewicz and Moustafa Gabr

JPM, 2024, 14, 68
DOI: 10.3390/jpm14010068

Approaches to mitigate the risk of serious adverse reactions in covalent drug design

Thomas A. Baillie

Expert Opinion on Drug Discovery, 2021, 16, 275
DOI: 10.1080/17460441.2021.1832079

Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies

Richard R. Furman, John C. Byrd, Roger G. Owen, Susan M. O’Brien, Jennifer R. Brown, Peter Hillmen, Deborah M. Stephens, Nataliya Chernyukhin, Tamara Lezhava, Ahmed M. Hamdy, Raquel Izumi, Priti Patel, Marshall Baek, Beth Christian, Martin J. S. Dyer, Matthew J. Streetly, Clare Sun, Simon Rule, Michael Wang, Paolo Ghia, Wojciech Jurczak, John M. Pagel and Jeff P. Sharman

Leukemia, 2021, 35, 3201
DOI: 10.1038/s41375-021-01252-y

Nucleophilie von Glutathion als Bindeglied zur Reaktivität von Michael‐Akzeptoren

Robert J. Mayer and Armin R. Ofial

Angewandte Chemie, 2019, 131, 17868
DOI: 10.1002/ange.201909803

Detection of an enzyme isomechanism by means of the kinetics of covalent inhibition

S.A. Adediran, Michael J. Morrison and R.F. Pratt

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2021, 1869, 140681
DOI: 10.1016/j.bbapap.2021.140681

Rational Design of Stapled Covalent Peptide Modifiers of Oncoprotein E6 from Human Papillomavirus

Cole Emanuelson, Yuta Naro, Olivia Shade, Melinda Liu, Sagar D. Khare and Alexander Deiters

ACS Chem. Biol., 2025, 20, 746
DOI: 10.1021/acschembio.4c00878

Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D

Ludovica S. Sirocchi, Maximilian Scharnweber, Sarah Oberndorfer, Gabriella Siszler, Krzysztof M. Zak, Klaus Rumpel, Ralph A. Neumüller and Birgit Wilding

J. Am. Chem. Soc., 2025, 147, 15787
DOI: 10.1021/jacs.5c03562

Advances in covalent drug discovery

Lydia Boike, Nathaniel J. Henning and Daniel K. Nomura

Nat Rev Drug Discov, 2022, 21, 881
DOI: 10.1038/s41573-022-00542-z

Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist

Parima Udompholkul, Ana Garza-Granados, Giulia Alboreggia, Carlo Baggio, Jack McGuire, Scott D. Pegan and Maurizio Pellecchia

J. Med. Chem., 2023, 66, 8159
DOI: 10.1021/acs.jmedchem.3c00467

Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation

Maëva M. Pichon, Dawid Drelinkiewicz, David Lozano, Ruxandra Moraru, Laura J. Hayward, Megan Jones, Michael A. McCoy, Samuel Allstrum-Graves, Dimitrios-Ilias Balourdas, Andreas C. Joerger, Richard J. Whitby, Stephen M. Goldup, Neil Wells, Graham J. Langley, Julie M. Herniman and Matthias G. J. Baud

Bioconjugate Chem., 2023, 34, 1679
DOI: 10.1021/acs.bioconjchem.3c00322

Covalent drug discovery using sulfur(VI) fluoride exchange warheads

Huang Huang and Lyn H. Jones

Expert Opinion on Drug Discovery, 2023, 18, 725
DOI: 10.1080/17460441.2023.2218642

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors

Jingting Zeng, Zhenshuo Luo, Tiansheng Zhao, Chunhua Xia, Fanglan Liu, Na Li, Lailiang Qu and Cheng Wang

Chem Biol Drug Des, 2025, 105
DOI: 10.1111/cbdd.70067

Mix-and-inject XFEL crystallography reveals gated conformational dynamics during enzyme catalysis

Medhanjali Dasgupta, Dominik Budday, Saulo H. P. de Oliveira, Peter Madzelan, Darya Marchany-Rivera, Javier Seravalli, Brandon Hayes, Raymond G. Sierra, Sébastien Boutet, Mark S. Hunter, Roberto Alonso-Mori, Alexander Batyuk, Jennifer Wierman, Artem Lyubimov, Aaron S. Brewster, Nicholas K. Sauter, Gregory A. Applegate, Virendra K. Tiwari, David B. Berkowitz, Michael C. Thompson, Aina E. Cohen, James S. Fraser, Michael E. Wall, Henry van den Bedem and Mark A. Wilson

Proc. Natl. Acad. Sci. U.S.A., 2019, 116, 25634
DOI: 10.1073/pnas.1901864116

Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective

Aimen Aljoundi, Imane Bjij, Ahmed El Rashedy and Mahmoud E. S. Soliman

Protein J, 2020, 39, 97
DOI: 10.1007/s10930-020-09884-2

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Daniel Zaidman, Paul Gehrtz, Mihajlo Filep, Daren Fearon, Ronen Gabizon, Alice Douangamath, Jaime Prilusky, Shirly Duberstein, Galit Cohen, C. David Owen, Efrat Resnick, Claire Strain-Damerell, Petra Lukacik, Haim Barr, Martin A. Walsh, Frank von Delft and Nir London

Cell Chemical Biology, 2021, 28, 1795
DOI: 10.1016/j.chembiol.2021.05.018

Stereodefined rhodium-catalysed 1,4-H/D delivery for modular syntheses and deuterium integration

Weiyi Wang, Yibo Yu, Bao Cheng, Huayi Fang, Xue Zhang, Hui Qian and Shengming Ma

Nat Catal, 2021, 4, 586
DOI: 10.1038/s41929-021-00643-9

Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics

Daniel Y. Yoo, Andrew D. Hauser, Stephen T. Joy, Dafna Bar-Sagi and Paramjit S. Arora

ACS Chem. Biol., 2020, 15, 1604
DOI: 10.1021/acschembio.0c00204

Synthesis and biological evaluation of colchicine and thiocolchicine derivatives bearing a Michael acceptor moiety in ring A

E. A. Mol’kova, E. S. Shchegravina, V. F. Otvagin, N. S. Kuzmina, Yu. B. Malysheva, E. V. Svirshchevskaya, E. A. Zaburdaeva and A. Yu. Fedorov

Russ Chem Bull, 2022, 71, 564
DOI: 10.1007/s11172-022-3449-7

Electrophile Scanning Reveals Reactivity Hotspots for the Design of Covalent Peptide Binders

Nathalie M. Grob, Clint Remarcik, Simon L. Rössler, Jeffrey Y. K. Wong, John C. K. Wang, Jason Tao, Corey L. Smith, Andrei Loas, Stephen L. Buchwald, Dan L. Eaton, Magdalena Preciado López and Bradley L. Pentelute

ACS Chem. Biol., 2024, 19, 101
DOI: 10.1021/acschembio.3c00538

Selective Covalent Targeting of Pyruvate Kinase M2 Using Arsenous Warheads

Jingyao Wang, Shaoqing Zhou, Yan Cheng, Lin Cheng, Ying Qin, Zhenfeng Zhang, Aiwei Bi, Huaijiang Xiang, Xinheng He, Xiaoxu Tian, Wenbin Liu, Jian Zhang, Chao Peng, Zhengjiang Zhu, Min Huang, Ying Li, Guanglei Zhuang and Li Tan

J. Med. Chem., 2023, 66, 2608
DOI: 10.1021/acs.jmedchem.2c01563

Synthesis of Guaianolide Analogues with a Tunable α-Methylene−γ-lactam Electrophile and Correlating Bioactivity with Thiol Reactivity

Paul A. Jackson, Henry A. M. Schares, Katherine F. M. Jones, John C. Widen, Daniel P. Dempe, Francois Grillet, Matthew E. Cuellar, Michael A. Walters, Daniel A. Harki and Kay M. Brummond

J. Med. Chem., 2020, 63, 14951
DOI: 10.1021/acs.jmedchem.0c01464

Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain

Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, Salomé Catalina Vilchez Larrea, Guillermo Daniel Alonso, Rafaela Salgado Ferreira, Wim Dehaen and Mario Alfredo Quevedo

Molecules, 2024, 29, 4224
DOI: 10.3390/molecules29174224

Site‐Selective Pyridine C−H Alkylation with Alcohols and Thiols via Single‐Electron Transfer of Frustrated Lewis Pairs

Chang‐Yin Tan, Myojeong Kim, Inyoung Park, Yuhyun Kim and Sungwoo Hong

Angewandte Chemie, 2022, 134
DOI: 10.1002/ange.202213857

Covalent hits and where to find them

Simon C.C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, Hannah Semple, Benjamin C. Whitehurst and Hua Xu

SLAS Discovery, 2024, 29, 100142
DOI: 10.1016/j.slasd.2024.01.003

Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1

Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Kendall Muzzarelli, Zahra Assar and Maurizio Pellecchia

J. Med. Chem., 2024, 67, 8172
DOI: 10.1021/acs.jmedchem.4c00277

Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary

Shujing Xu, Dang Ding, Xujie Zhang, Lin Sun, Dongwei Kang, Boshi Huang, Xinyong Liu and Peng Zhan

Molecules, 2022, 27, 850
DOI: 10.3390/molecules27030850

Biospecific Chemistry for Covalent Linking of Biomacromolecules

Li Cao and Lei Wang

Chem. Rev., 2024, 124, 8516
DOI: 10.1021/acs.chemrev.4c00066

Targeted degradation of Pin1 by protein-destabilizing compounds

Giulia Alboreggia, Parima Udompholkul, Isaac Rodriguez, Gregor Blaha and Maurizio Pellecchia

Proc. Natl. Acad. Sci. U.S.A., 2024, 121
DOI: 10.1073/pnas.2403330121

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease

Haixia Su, Sheng Yao, Wenfeng Zhao, Yumin Zhang, Jia Liu, Qiang Shao, Qingxing Wang, Minjun Li, Hang Xie, Weijuan Shang, Changqiang Ke, Lu Feng, Xiangrui Jiang, Jingshan Shen, Gengfu Xiao, Hualiang Jiang, Leike Zhang, Yang Ye and Yechun Xu

Nat Commun, 2021, 12
DOI: 10.1038/s41467-021-23751-3

Measurement and utilization of the proteomic reactivity by mass spectrometry

Clodette Punzalan, Lei Wang, Bekim Bajrami and Xudong Yao

Mass Spectrometry Reviews, 2024, 43, 166
DOI: 10.1002/mas.21837

Practical Perspectives and Roles of XRD in Drug Discovery: A Review

Ashish Mehta, Rahul Makhija, Pallavi Barik, Shubham Dhiman, Ghanshyam Das Gupta and Vivek Asati

CAC, 2024, 20, 449
DOI: 10.2174/0115734110296435240323113938

FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance

Zhijie Wang, Jiongheng Cai, Jie Cheng, Wenqianzi Yang, Yifan Zhu, Hongmei Li, Tao Lu, Yadong Chen and Shuai Lu

J. Med. Chem., 2021, 64, 2878
DOI: 10.1021/acs.jmedchem.0c01851

Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction

Yunyuan Huang, Yixiang Xu, Rongrong Song, Shuaishuai Ni, Jiaqi Liu, Yanhong Xu, Yanliang Ren, Li Rao, Yingjie Wang, Lin Wei, Lingling Feng, Chen Su, Chao Peng, Jian Li and Jian Wan

J. Med. Chem., 2020, 63, 6238
DOI: 10.1021/acs.jmedchem.0c00699

Mass Spectrometry-Based Protein Footprinting for Higher-Order Structure Analysis: Fundamentals and Applications

Xiaoran Roger Liu, Mengru Mira Zhang and Michael L. Gross

Chem. Rev., 2020, 120, 4355
DOI: 10.1021/acs.chemrev.9b00815

Catechol-based inhibitors of bacterial urease

Aikaterini Pagoni, Theohari Daliani, Katarzyna Macegoniuk, Stamatia Vassiliou and Łukasz Berlicki

Bioorganic & Medicinal Chemistry Letters, 2019, 29, 1085
DOI: 10.1016/j.bmcl.2019.02.032

Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions

Luca Gambini, Parima Udompholkul, Ahmed F. Salem, Carlo Baggio and Maurizio Pellecchia

ChemMedChem, 2020, 15, 2176
DOI: 10.1002/cmdc.202000355

Protocol for Stereoselective Construction of Highly Functionalized Dienyl Sulfonyl Fluoride Warheads

Zai-Wei Zhang, Shi-Meng Wang, Wan-Yin Fang, Ravindar Lekkala and Hua-Li Qin

J. Org. Chem., 2020, 85, 13721
DOI: 10.1021/acs.joc.0c01877

Ultrasound Guided Local Delivery of Bioorthogonal PDL1 Degrader for Enhanced Immunotherapy

Lantian Wang, Zhaoyou Liu, Panpan Ji, Jiao Ma, Ke Mou, Tian Zhou, Yuan Liang, Bin Zhang, Mengying Wei, Guodong Yang, Wenqi Sun, Li Gong and Lijun Yuan

Small, 2025, 21
DOI: 10.1002/smll.202405549

Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C

Jason G. Kettle, Sharan K. Bagal, Sue Bickerton, Michael S. Bodnarchuk, Jason Breed, Rodrigo J. Carbajo, Doyle J. Cassar, Atanu Chakraborty, Sabina Cosulich, Iain Cumming, Michael Davies, Andrew Eatherton, Laura Evans, Lyman Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Stephanie Harlfinger, Lyndsey Hanson, Martin Howard, Rachel Howells, Anne Jackson, Paul Kemmitt, Jennifer K. Kingston, Scott Lamont, Hilary J. Lewis, Songlei Li, Libin Liu, Derek Ogg, Christopher Phillips, Radek Polanski, Graeme Robb, David Robinson, Sarah Ross, James M. Smith, Michael Tonge, Rebecca Whiteley, Junsheng Yang, Longfei Zhang and Xiliang Zhao

J. Med. Chem., 2020, 63, 4468
DOI: 10.1021/acs.jmedchem.9b01720

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

Haidée Aranda-Tavío, Carlota Recio, Pedro Martín-Acosta, Miguel Guerra-Rodríguez, Yeray Brito-Casillas, Rosa Blanco, Vanessa Junco, Javier León, Juan Carlos Montero, Lucía Gandullo-Sánchez, Grant McNaughton-Smith, Juan Manuel Zapata, Atanasio Pandiella, Angel Amesty, Ana Estévez-Braun, Leandro Fernández-Pérez and Borja Guerra

Biomedicine & Pharmacotherapy, 2021, 144, 112330
DOI: 10.1016/j.biopha.2021.112330

Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells

Alexander P. Sobinoff, Salvatore Di Maro, Ronnie Ren Jie Low, Rosaria Benedetti, Stefano Tomassi, Antonia D'Aniello, Rosita Russo, Ilaria Baglivo, Ugo Chianese, Paolo V. Pedone, Angela Chambery, Anthony J. Cesare, Lucia Altucci, Hilda A. Pickett and Sandro Cosconati

Cell Chemical Biology, 2023, 30, 1652
DOI: 10.1016/j.chembiol.2023.11.008

How Reactive are Druggable Cysteines in Protein Kinases?

Ernest Awoonor-Williams and Christopher N. Rowley

J. Chem. Inf. Model., 2018, 58, 1935
DOI: 10.1021/acs.jcim.8b00454

Perspectives on Computational Enzyme Modeling: From Mechanisms to Design and Drug Development

Kwangho Nam, Yihan Shao, Dan T. Major and Magnus Wolf-Watz

ACS Omega, 2024
DOI: 10.1021/acsomega.3c09084

Enhanced Suppression of a Protein–Protein Interaction in Cells Using Small-Molecule Covalent Inhibitors Based on an N-Acyl-N-alkyl Sulfonamide Warhead

Tsuyoshi Ueda, Tomonori Tamura, Masaharu Kawano, Keiya Shiono, Fruzsina Hobor, Andrew J. Wilson and Itaru Hamachi

J. Am. Chem. Soc., 2021, 143, 4766
DOI: 10.1021/jacs.1c00703

Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design

Namrashee V. Mehta, Arundhati Abhyankar and Mariam S. Degani

European Journal of Medicinal Chemistry, 2023, 260, 115761
DOI: 10.1016/j.ejmech.2023.115761

Reactive Docking: A Computational Method for High-Throughput Virtual Screenings of Reactive Species

Giulia Bianco, Matthew Holcomb, Diogo Santos-Martins, Andreas Tillack, Althea Hansel-Harris and Stefano Forli

J. Chem. Inf. Model., 2023, 63, 5631
DOI: 10.1021/acs.jcim.3c00832

Precious Cargo: The Role of Polymeric Nanoparticles in the Delivery of Covalent Drugs

Daniel Weissberger, Martina H. Stenzel and Luke Hunter

Molecules, 2024, 29, 4949
DOI: 10.3390/molecules29204949

Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton

Jun Liu, Lin Li, Xiaobin Li, Xin Wang, Xiaoyu Zhao, Yanan Qiao, Yuliang Xu, Yong Sun, Lilin Qian, Zhaopeng Liu, Aiguo Ji and Hongxiang Lou

European Journal of Medicinal Chemistry, 2021, 209, 112896
DOI: 10.1016/j.ejmech.2020.112896

Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors

Shengrong Li, Pengwei Zhang, Fang Xu, Shengcao Hu, Jiacong Liu, Yi Tan, Zhengchao Tu, Hongyan Sun, Zhi-Min Zhang, Qing-Yu He, Pinghua Sun, Ke Ding and Zhengqiu Li

J. Med. Chem., 2022, 65, 10408
DOI: 10.1021/acs.jmedchem.2c00272

Targeted Covalent Inhibition: A Prospective Way to Develop Novel HSP90 C-terminal Inhibitor

Yajun Liu and Yajing Li

CDT, 2022, 23, 1454
DOI: 10.2174/1389450123666220920111841

Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors

Kirsten McAulay, Emily A. Hoyt, Morgan Thomas, Marianne Schimpl, Michael S. Bodnarchuk, Hilary J. Lewis, Derek Barratt, Deepa Bhavsar, David M. Robinson, Michael J. Deery, Derek J. Ogg, Gonçalo J. L. Bernardes, Richard A. Ward, Michael J. Waring and Jason G. Kettle

J. Am. Chem. Soc., 2020, 142, 10358
DOI: 10.1021/jacs.9b13391

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)

Scott H. Watterson, Qingjie Liu, Myra Beaudoin Bertrand, Douglas G. Batt, Ling Li, Mark A. Pattoli, Stacey Skala, Lihong Cheng, Mary T. Obermeier, Robin Moore, Zheng Yang, Rodney Vickery, Paul A. Elzinga, Lorell Discenza, Celia D’Arienzo, Kathleen M. Gillooly, Tracy L. Taylor, Claudine Pulicicchio, Yifan Zhang, Elizabeth Heimrich, Kim W. McIntyre, Qian Ruan, Richard A. Westhouse, Ian M. Catlett, Naiyu Zheng, Charu Chaudhry, Jun Dai, Michael A. Galella, Andrew J. Tebben, Matt Pokross, Jianqing Li, Rulin Zhao, Daniel Smith, Richard Rampulla, Alban Allentoff, Michael A. Wallace, Arvind Mathur, Luisa Salter-Cid, John E. Macor, Percy H. Carter, Aberra Fura, James R. Burke and Joseph A. Tino

J. Med. Chem., 2019, 62, 3228
DOI: 10.1021/acs.jmedchem.9b00167

Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease

Meijun Liu, Binghong Xu, Yuying Ma, Luqing Shang, Sheng Ye and Yaxin Wang

Antiviral Research, 2021, 192, 105102
DOI: 10.1016/j.antiviral.2021.105102

Light-driven post-translational installation of reactive protein side chains

Brian Josephson, Charlie Fehl, Patrick G. Isenegger, Simon Nadal, Tom H. Wright, Adeline W. J. Poh, Ben J. Bower, Andrew M. Giltrap, Lifu Chen, Christopher Batchelor-McAuley, Grace Roper, Oluwatobi Arisa, Jeroen B. I. Sap, Akane Kawamura, Andrew J. Baldwin, Shabaz Mohammed, Richard G. Compton, Veronique Gouverneur and Benjamin G. Davis

Nature, 2020, 585, 530
DOI: 10.1038/s41586-020-2733-7

Targeted Covalent Inhibitors for Novel Therapeutics

Jingya Zhang, Wenshuo Gao, Yixia Wang, Junbiao Chang and Bin Yu

Future Med. Chem., 2023, 15, 1739
DOI: 10.4155/fmc-2023-0243

Visible‐Light‐Induced Cysteine‐Specific Bioconjugation: Biocompatible Thiol–Ene Click Chemistry

Hangyeol Choi, Myojeong Kim, Jaebong Jang and Sungwoo Hong

Angew Chem Int Ed, 2020, 59, 22514
DOI: 10.1002/anie.202010217

Recent progress in covalent warheads for in vivo targeting of endogenous proteins

Naoya Shindo and Akio Ojida

Bioorganic & Medicinal Chemistry, 2021, 47, 116386
DOI: 10.1016/j.bmc.2021.116386

Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?

Qiuyao Huang, Yan Zhong, Hui Dong, Qiyao Zheng, Shuo Shi, Kai Zhu, Xinming Qu, Wenhao Hu, Xiaolei Zhang and Yuanxiang Wang

European Journal of Medicinal Chemistry, 2020, 187, 111922
DOI: 10.1016/j.ejmech.2019.111922

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Claudia Fumarola, Nicole Bozza, Riccardo Castelli, Francesca Ferlenghi, Giuseppe Marseglia, Alessio Lodola, Mara Bonelli, Silvia La Monica, Daniele Cretella, Roberta Alfieri, Roberta Minari, Maricla Galetti, Marcello Tiseo, Andrea Ardizzoni, Marco Mor and Pier Giorgio Petronini

Front. Oncol., 2019, 9
DOI: 10.3389/fonc.2019.00179

A General Protocol for the Chemo- and Stereoselective Construction of α,β-Unsaturated γ-Amino Sulfonyl Fluorides

Xiang-Feng Tao and Hua-Li Qin

Synthesis, 2023, 55, 3373
DOI: 10.1055/s-0041-1738449

Dual roles of drug or its metabolite−protein conjugate: Cutting‐edge strategy of drug discovery using shotgun proteomics

Shilin Gong, Xiaolan Hu, Shengshuang Chen, Baoqing Sun, Jian‐Lin Wu and Na Li

Medicinal Research Reviews, 2022, 42, 1704
DOI: 10.1002/med.21889

The influence of multiple oral administration on the pharmacokinetics and distribution profile of dalcetrapib in rats

Hiroaki Takubo, Tomohiro Ishikawa, Toshio Taniguchi, Kazunori Iwanaga and Yukihiro Nomura

Xenobiotica, 2021, 51, 82
DOI: 10.1080/00498254.2020.1809030

X-ray Screening of an Electrophilic Fragment Library and Application toward the Development of a Novel ERK 1/2 Covalent Inhibitor

Jeffrey D. St. Denis, Gianni Chessari, Anne Cleasby, Benjamin D. Cons, Suzanna Cowan, Samuel E. Dalton, Charlotte East, Christopher W. Murray, Marc O’Reilly, Torren Peakman, Magdalini Rapti and Jessie L. Stow

J. Med. Chem., 2022, 65, 12319
DOI: 10.1021/acs.jmedchem.2c01044

Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold

Huifang Shan, Xinyu Ma, Guoyi Yan, Meng Luo, Xinxin Zhong, Suke Lan, Jie Yang, Yuanyuan Liu, Chunlan Pu, Yu Tong and Rui Li

European Journal of Medicinal Chemistry, 2021, 219, 113432
DOI: 10.1016/j.ejmech.2021.113432

Synthetic Methodology-driven Chemical Protein Modifications

Katsuya Maruyama and Motomu Kanai

Chem. Lett., 2019, 48, 1421
DOI: 10.1246/cl.190652

A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine

Francesca Ferlenghi, Laura Scalvini, Federica Vacondio, Riccardo Castelli, Nicole Bozza, Giuseppe Marseglia, Silvia Rivara, Alessio Lodola, Silvia La Monica, Roberta Minari, Pier Giorgio Petronini, Roberta Alfieri, Marcello Tiseo and Marco Mor

European Journal of Medicinal Chemistry, 2021, 225, 113786
DOI: 10.1016/j.ejmech.2021.113786

Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds

Matic Proj, Damijan Knez, Izidor Sosič and Stanislav Gobec

Drug Discovery Today, 2022, 27, 1733
DOI: 10.1016/j.drudis.2022.03.008

Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story

Ruxandra Moraru, Beatriz Valle-Argos, Annabel Minton, Lara Buermann, Suyin Pan, Thomas E. Wales, Raji E. Joseph, Amy H. Andreotti, Jonathan C. Strefford, Graham Packham and Matthias G. J. Baud

J. Med. Chem., 2024, 67, 13572
DOI: 10.1021/acs.jmedchem.3c01927

Peptide‐based covalent inhibitors of protein–protein interactions

Felix M. Paulussen and Tom N. Grossmann

Journal of Peptide Science, 2023, 29
DOI: 10.1002/psc.3457

Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans

Terry Podoll, Paul G. Pearson, Jerry Evarts, Tim Ingallinera, Elena Bibikova, Hao Sun, Mark Gohdes, Kristen Cardinal, Mitesh Sanghvi and J. Greg Slatter

Drug Metabolism and Disposition, 2019, 47, 145
DOI: 10.1124/dmd.118.084459

Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

Miguel Guerra-Rodríguez, Priscila López-Rojas, Ángel Amesty, Haidée Aranda-Tavío, Yeray Brito-Casillas, Ana Estévez-Braun, Leandro Fernández-Pérez, Borja Guerra and Carlota Recio

Cancers, 2022, 14, 5174
DOI: 10.3390/cancers14215174

Catalysis medicine: Participating in the chemical networks of living organisms through catalysts

Motomu Kanai and Yuma Takeuchi

Tetrahedron, 2023, 131, 133227
DOI: 10.1016/j.tet.2022.133227

Reactive chemistry for covalent probe and therapeutic development

R. Justin Grams and Ku-Lung Hsu

Trends in Pharmacological Sciences, 2022, 43, 249
DOI: 10.1016/j.tips.2021.12.002

B-nor-methylene Colchicinoid PT-100 Selectively Induces Apoptosis in Multidrug-Resistant Human Cancer Cells via an Intrinsic Pathway in a Caspase-Independent Manner

Andreas Stein, Persefoni Hilken née Thomopoulou, Corazon Frias, Sina M. Hopff, Paloma Varela, Nicola Wilke, Arul Mariappan, Jörg-Martin Neudörfl, Alexey Yu Fedorov, Jay Gopalakrishnan, Benoît Gigant, Aram Prokop and Hans-Günther Schmalz

ACS Omega, 2022, 7, 2591
DOI: 10.1021/acsomega.1c04659

Strategy for cysteine-targeting covalent inhibitors screening using in-house database based LC-MS/MS and drug repurposing

Xiaolan Hu, Jian-Lin Wu, Quan He, Zhi-Qi Xiong and Na Li

Journal of Pharmaceutical Analysis, 2025, 15, 101045
DOI: 10.1016/j.jpha.2024.101045

Evaluation of the changes in exposure to thiol compounds in chronic kidney disease patients using the PBPK model

Hiroaki Takubo, Toshio Taniguchi, Kazunori Iwanaga and Yukihiro Nomura

Xenobiotica, 2021, 51, 31
DOI: 10.1080/00498254.2020.1805816

The art of suicidal molecular seduction for targeting drug resistance

Mohammad Hassan Moshafi, Saeid Ghasemshirazi and Ardavan Abiri

Medical Hypotheses, 2020, 140, 109676
DOI: 10.1016/j.mehy.2020.109676

Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory

Hartmut Beck, Michael Härter, Bastian Haß, Carsten Schmeck and Lars Baerfacker

Drug Discovery Today, 2022, 27, 1560
DOI: 10.1016/j.drudis.2022.02.015

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection

Rui Ge, Zuyuan Shen, Jian Yin, Wenhua Chen, Qi Zhang, Yulong An, Dewei Tang, Alexander L. Satz, Wenji Su and Letian Kuai

SLAS Discovery, 2022, 27, 79
DOI: 10.1016/j.slasd.2022.01.001

Covalent Affibody‐Molecular Glue Drug Conjugate Nanoagent for Proximity‐Enabled Reactive Therapeutics

Wenhui Gao, Xiaoyuan Yang, Qingrong Li, Yingchun Liu, Wei Huang, Xuelin Xia and Deyue Yan

Advanced Science, 2025, 12
DOI: 10.1002/advs.202412273

Visible‐Light‐Induced Cysteine‐Specific Bioconjugation: Biocompatible Thiol–Ene Click Chemistry

Hangyeol Choi, Myojeong Kim, Jaebong Jang and Sungwoo Hong

Angewandte Chemie, 2020, 132, 22703
DOI: 10.1002/ange.202010217

Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity

Yaoguang Huang, Wenwu Liu, Changhao Zhao, Xiaoyu Shi, Qingchun Zhao, Jingming Jia and Anhua Wang

European Journal of Medicinal Chemistry, 2024, 275, 116547
DOI: 10.1016/j.ejmech.2024.116547

Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases

Datong Zhang, He Gong and Fancui Meng

Molecules, 2021, 26, 4907
DOI: 10.3390/molecules26164907

Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors

Xiaoyun Lu, Jeff B. Smaill, Adam V. Patterson and Ke Ding

J. Med. Chem., 2022, 65, 58
DOI: 10.1021/acs.jmedchem.1c01719

Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

Theresa Klett, Martin Schwer, Larissa Ernst, Marc Engelhardt, Simon Jaag, Benedikt Masberg, Cornelius Knappe, Michael Lämmerhofer, Matthias Gehringer and Frank Boeckler

DDDT, 2024, Volume 18, 2653
DOI: 10.2147/DDDT.S466829

Avoiding Drug Resistance in HIV Reverse Transcriptase

Maria E. Cilento, Karen A. Kirby and Stefan G. Sarafianos

Chem. Rev., 2021, 121, 3271
DOI: 10.1021/acs.chemrev.0c00967

High performance liquid chromatographic assays with UV-detection for evaluation of inhibitors of acetylcholinesterase and butyrylcholinesterase

Giulia Michels and Matthias Lehr

Journal of Liquid Chromatography & Related Technologies, 2021, 44, 309
DOI: 10.1080/10826076.2021.1925908

Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities

Robert J. Mayer and Armin R. Ofial

Angew Chem Int Ed, 2019, 58, 17704
DOI: 10.1002/anie.201909803

An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study

Snehasis Banerjee

Biophysical Chemistry, 2021, 269, 106510
DOI: 10.1016/j.bpc.2020.106510

Identification of peroxiredoxin 6 as a direct target of withangulatin A by quantitative chemical proteomics in non-small cell lung cancer

Chen Chen, Lijie Gong, Xiaoqin Liu, Tianyu Zhu, Wuxi Zhou, Lingyi Kong and Jianguang Luo

Redox Biology, 2021, 46, 102130
DOI: 10.1016/j.redox.2021.102130

Systematic Study of the Glutathione Reactivity of N-Phenylacrylamides: 2. Effects of Acrylamide Substitution

Adam Birkholz, David J. Kopecky, Laurie P. Volak, Michael D. Bartberger, Yuping Chen, Christopher M. Tegley, Tara Arvedson, John D. McCarter, Christopher Fotsch and Victor J. Cee

J. Med. Chem., 2020, 63, 11602
DOI: 10.1021/acs.jmedchem.0c00749

Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase

Xinya Han, Yunyuan Huang, Lin Wei, Haifeng Chen, Yanrong Guo, Zilong Tang, Wei Hu, Qinfei Xia, Qi Wang, Jufen Yan and Yanliang Ren

Bioorganic & Medicinal Chemistry, 2020, 28, 115624
DOI: 10.1016/j.bmc.2020.115624

Chemo-Selective Cys–Pen Disulfide for Proximity-Induced Cysteine Cross-Linking

Mei-miao Zhan, Rui Wang, Zhihong Liu, Na Liu, Yuxin Ye, Mingchan Liang, Yichi Zhang, Chenran Jiang, Feng Yin and Zigang Li

ACS Chem. Biol., 2022, 17, 521
DOI: 10.1021/acschembio.2c00083

Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE−/− mice through covalently binding to IKKβ and inhibiting NF-κB-mediated inflammation

Zhu-qi Huang, Wu Luo, Wei-xin Li, Pan Chen, Zhe Wang, Rui-jie Chen, Yi Wang, Wei-jian Huang and Guang Liang

Acta Pharmacol Sin, 2023, 44, 58
DOI: 10.1038/s41401-022-00928-0

Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors

Giulia Bianco, David S. Goodsell and Stefano Forli

Trends in Pharmacological Sciences, 2020, 41, 1038
DOI: 10.1016/j.tips.2020.10.005

Site‐Selective Pyridine C−H Alkylation with Alcohols and Thiols via Single‐Electron Transfer of Frustrated Lewis Pairs

Chang‐Yin Tan, Myojeong Kim, Inyoung Park, Yuhyun Kim and Sungwoo Hong

Angew Chem Int Ed, 2022, 61
DOI: 10.1002/anie.202213857

Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions

Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge-Fei Hao and Guang-Fu Yang

Trends in Biochemical Sciences, 2023, 48, 539
DOI: 10.1016/j.tibs.2023.01.008

Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation

Lin Wei, Wuqiang Wen, Li Rao, Yunyuan Huang, Mengting Lei, Kai Liu, Saiya Hu, Rongrong Song, Yanliang Ren and Jian Wan

J. Chem. Inf. Model., 2020, 60, 4388
DOI: 10.1021/acs.jcim.9b01197

Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation

Adam M. Thomas, Marta Serafini, Emma K. Grant, Edward A. J. Coombs, Joseph P. Bluck, Matthias Schiedel, Michael A. McDonough, Jessica K. Reynolds, Bernadette Lee, Michael Platt, Vassilena Sharlandjieva, Philip C. Biggin, Fernanda Duarte, Thomas A. Milne, Jacob T. Bush and Stuart J. Conway

ACS Chem. Biol., 2023, 18, 2405
DOI: 10.1021/acschembio.3c00437

From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series

Anže Meden, Damijan Knez, Xavier Brazzolotto, Florian Nachon, Jose Dias, Jurij Svete, Jure Stojan, Uroš Grošelj and Stanislav Gobec

European Journal of Medicinal Chemistry, 2022, 234, 114248
DOI: 10.1016/j.ejmech.2022.114248

Development of an Irreversible Peptidomimetic Radioligand for PET Imaging of ST14 Protease

Tukang Peng, Gang Huang, Haitao Zhao and Jianjun Liu

Bioconjugate Chem., 2025, 36, 116
DOI: 10.1021/acs.bioconjchem.4c00564

Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease

Ying Wang, Qiushuang Gao, Peng Yao, Qizheng Yao and Ji Zhang

Journal of Biomolecular Structure and Dynamics, 2023, 41, 15262
DOI: 10.1080/07391102.2023.2193994

Precision Targeting of Endogenous Epidermal Growth Factor Receptor (EGFR) by Structurally Aligned Dual-Modifier Labeling

Ivan de Jesus Salazar-Estrada, Karthik Shantharam Kamath and Fei Liu

ACS Pharmacol. Transl. Sci., 2022, 5, 859
DOI: 10.1021/acsptsci.2c00155

Removing Neighboring Ring Influence in Monocyclic B–OH Diazaborines: Properties and Reactivity as Phenolic Bioisosteres with Dynamic Hydroxy Exchange

Jake J. Blackner, Olivia M. Schneider, Warren O. Wong and Dennis G. Hall

J. Am. Chem. Soc., 2024, 146, 19499
DOI: 10.1021/jacs.4c06360

Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain

Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, Salomé Catalina Vilchez Larrea, Guillermo Daniel Alonso, Rafaela Salgado Ferreira, Mario Alfredo Quevedo and Wim Dehaen

ACS Med. Chem. Lett., 2025, 16, 72
DOI: 10.1021/acsmedchemlett.4c00460

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics

Qingke Li, Qu Chen, Paul C. Klauser, Mengyuan Li, Feng Zheng, Nanxi Wang, Xiaoying Li, Qianbing Zhang, Xuemei Fu, Qian Wang, Yang Xu and Lei Wang

Cell, 2020, 182, 85
DOI: 10.1016/j.cell.2020.05.028

Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor

Amit Shraga, Evgenia Olshvang, Natalia Davidzohn, Payam Khoshkenar, Nicolas Germain, Khriesto Shurrush, Silvia Carvalho, Liat Avram, Shira Albeck, Tamar Unger, Bruce Lefker, Chakrapani Subramanyam, Robert L. Hudkins, Amir Mitchell, Ziv Shulman, Takayoshi Kinoshita and Nir London

Cell Chemical Biology, 2019, 26, 98
DOI: 10.1016/j.chembiol.2018.10.011